Antimicrobial Agents Practice Questions

Q: Which of the following causes retinal pigmentation?

Chloroquine. ***Chloroquine*** - Chloroquine can cause **retinal toxicity**, leading to **pigmentary changes** and potentially irreversible vision loss, particularly with prolonged use or high doses. - The characteristic finding is often described as **"bull's eye maculopathy,"** a central area of depigmentation surrounded by a ring of hyperpigmentation in the macula. *Quinine* - Quinine is known for causing **cinchonism**, which includes symptoms like **tinnitus**, headache, and blurred vision, but not typically retinal pigmentation. - While it can cause **visual disturbances**, these are usually related to **optic nerve toxicity** or vascular changes, not direct pigmentary retinopathy. *Mefloquine* - Mefloquine is associated with **neuropsychiatric side effects**, such as vivid dreams, anxiety, depression, and hallucinations, but not retinal pigmentation. - Its adverse ocular effects are less common than with chloroquine and do not typically involve permanent pigmentary changes to the retina. *Atovaquone* - Atovaquone is generally well-tolerated with common side effects including gastrointestinal upset, headache, and rash. - It is **not known to cause retinal pigmentation** or significant ocular toxicity.

Q: Which compound is primarily responsible for the hepatotoxicity associated with Isoniazid (INH)?

INH acetylhydrazine. ***INH acetylhydrazine*** - The hepatotoxicity of Isoniazid (INH) is primarily attributed to **acetylhydrazine**, a toxic metabolite formed during INH metabolism - **Metabolic pathway:** INH is first acetylated by N-acetyltransferase 2 (NAT2) to form acetylisoniazid, which then hydrolyzes to **acetylhydrazine** and isonicotinic acid - Acetylhydrazine is further oxidized by **cytochrome P450 2E1 (CYP2E1)** to form highly reactive intermediates that covalently bind to hepatic macromolecules, causing **hepatocellular injury** - **Risk factors:** Rapid acetylators, concurrent alcohol use, and CYP2E1 inducers increase acetylhydrazine formation and hepatotoxicity risk - This is the well-established mechanism of INH-induced hepatitis in clinical pharmacology *INH sulfhydrazine* - Sulfhydrazine is not a metabolite of isoniazid - INH metabolism involves acetylation and hydrolysis, not sulfonation pathways - This compound is not implicated in INH hepatotoxicity *INH methylhydrazine* - Methylhydrazine is not formed during isoniazid metabolism - The metabolic pathway of INH involves acetylation, not methylation - While hydrazine compounds can be hepatotoxic, methylhydrazine is not relevant to INH toxicity *None of the options* - This is incorrect as acetylhydrazine (listed as "INH acetylhydrazine") is indeed the primary toxic metabolite responsible for hepatotoxicity

Q: What is the approximate incidence of hepatotoxicity in patients receiving HAART?

10%. ***10%*** - The incidence of **hepatotoxicity** among patients on **HAART** (Highly Active Antiretroviral Therapy) is estimated to be around 10%. - This adverse effect can range from mild, asymptomatic enzyme elevations to **severe liver injury**. *20%* - While hepatotoxicity is a known complication of HAART, an incidence of 20% is generally considered higher than the average reported rates in most studies. - Higher rates might be encountered in specific high-risk populations, such as those with pre-existing liver disease or co-infection with viral hepatitis, but not as a general approximation. *30%* - An incidence of 30% for HAART-induced hepatotoxicity is significantly higher than typically observed and would suggest a higher level of risk than is generally presented in clinical literature. - Such high rates are usually associated with specific, older regimens or very vulnerable patient groups. *40%* - An incidence of 40% is exceptionally high for HAART-induced hepatotoxicity and would indicate a severe and frequent adverse reaction, which is not characteristic of modern HAART regimens. - This figure is not representative of the general incidence in patients receiving contemporary antiretroviral therapy.

Q: What are the active ingredients in Savlon antiseptic?

Cetrimide + Chlorhexidine. ***Cetrimide + Chlorhexidine*** - Savlon antiseptic liquid contains **cetrimide (0.5%)** and **chlorhexidine gluconate (0.1%)** as its active ingredients - This combination provides **broad-spectrum antiseptic activity** with complementary mechanisms - **Cetrimide** acts as a quaternary ammonium compound with surfactant and detergent properties, disrupting bacterial cell membranes - **Chlorhexidine** provides prolonged antimicrobial action by binding to bacterial cell walls and disrupting membrane integrity - This is the **standard formulation** used in Savlon antiseptic liquid *Cetrimide + Chlorhexidine + butyl alcohol* - While cetrimide and chlorhexidine are the active ingredients, **butyl alcohol is not listed as a primary active antiseptic ingredient** in standard Savlon formulation - Butyl alcohol may be present as a **solvent or excipient** but not as an active antiseptic agent *Cetrimide + butyl alcohol* - This combination **omits chlorhexidine**, which is a crucial component for Savlon's antiseptic efficacy - Butyl alcohol is not an active antiseptic ingredient in Savlon *Cetrimide + Cetavlon* - **Cetavlon is a trade name** for preparations containing cetrimide itself, not a separate active ingredient - This option represents a **redundancy** as it essentially lists cetrimide twice under different names

Q: Which of the following is a topical antifungal agent?

Butenafine. ***Butenafine*** - **Butenafine** belongs to the class of **benzylamine antifungals** and is used topically to treat fungal infections such as **tinea pedis (athlete's foot)**, **tinea cruris (jock itch)**, and **tinea corporis (ringworm)**. - Its mechanism of action involves inhibiting **squalene epoxidase**, an enzyme essential for fungal cell membrane synthesis, leading to **ergosterol depletion** and accumulation of squalene, which is toxic to the fungus. *Benzyl benzoate* - **Benzyl benzoate** is primarily used as a **topical scabicide** and **pediculicide**, meaning it targets mites (scabies) and lice. - It works by acting as a **neurotoxin** to these parasites, causing paralysis and death, and is not classified as an antifungal agent. *Brimetenide* - This option appears to be a **misspelling** or **non-existent drug name** in common pharmaceutical contexts. - There is no widely recognized drug with the name **"Brimetenide"** that serves as an antifungal. *Posaconazole* - **Posaconazole** is a **systemic triazole antifungal**, typically administered orally or intravenously for the treatment and prophylaxis of invasive fungal infections in immunocompromised patients. - While it is an antifungal, its primary use is **systemic** rather than topical for treating superficial dermatophyte infections.

Q: For systemic mycosis, fluconazole is preferred over ketoconazole because of:

All of the options. ***All of the options*** Fluconazole is preferred over ketoconazole for systemic mycoses due to multiple superior pharmacological properties: **Greater Efficacy:** - Fluconazole has **excellent bioavailability** (>90% oral) and superior tissue penetration, especially into the CNS and CSF - Highly effective against **Candida species** (including systemic candidiasis) and **Cryptococcus neoformans** (cryptococcal meningitis) - Ketoconazole has poor CNS penetration, making it unsuitable for deep-seated infections **Longer Half-life (t1/2):** - Fluconazole has a **half-life of ~30 hours**, enabling **once-daily dosing** - Ketoconazole has a half-life of ~8 hours, requiring multiple daily doses - Longer half-life improves patient compliance and maintains therapeutic drug levels **Lesser Side Effects:** - Fluconazole has **minimal hepatotoxicity** and is generally well-tolerated - Ketoconazole causes **significant hepatotoxicity** (black box warning) and **endocrine disturbances** by blocking steroid synthesis (gynecomastia, decreased testosterone, adrenal suppression) - Fluconazole does not interfere with steroid hormone synthesis at therapeutic doses **Clinical Practice:** Due to these combined advantages, ketoconazole is now rarely used for systemic mycoses and is primarily reserved for topical applications or specific resistant dermatophyte infections.

Q: Typhoid is treated by all except

Erythromycin. ***Erythromycin*** - **Erythromycin** is a macrolide antibiotic primarily effective against Gram-positive bacteria and atypical bacteria. - It has **NO role** in the treatment of typhoid fever as it lacks adequate activity against *Salmonella typhi* and does not achieve therapeutic intracellular concentrations. - Unlike azithromycin (another macrolide), erythromycin has poor intracellular penetration and is **never used** for typhoid. *Ceftriaxone* - **Ceftriaxone** is a third-generation cephalosporin that is highly effective against *Salmonella typhi*. - It is a **first-line treatment** for severe typhoid fever and is preferred in regions with fluoroquinolone resistance. - Dosage: 2-4 g IV daily for 10-14 days. *Amikacin* - **Amikacin** is an aminoglycoside with generally poor intracellular penetration, making it suboptimal for treating intracellular pathogens. - While **not a standard agent** for typhoid, it has been used in **rare cases of extensively drug-resistant (XDR) typhoid** as part of combination therapy, particularly in outbreaks where other options have failed. - It is **not a recommended first-line or routine agent** due to limited efficacy, potential toxicity (nephrotoxicity and ototoxicity), and availability of better alternatives. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone with excellent intracellular penetration and was historically the **first-line oral treatment** for uncomplicated typhoid fever. - Its efficacy against *Salmonella typhi* made it the preferred agent for decades. - However, widespread **fluoroquinolone resistance** has emerged in South Asia, limiting its current use as empirical first-line therapy in many regions.

Q: Which antifungal can be used orally but not intravenously?

Griseofulvin. ***Griseofulvin*** - **Griseofulvin** is an oral antifungal agent primarily used for dermatophyte infections [2], and it is **not available** or administered intravenously. - Its mechanism involves binding to **keratin** in newly forming skin, hair, and nails, preventing fungal invasion. *Voriconazole* - **Voriconazole** is a broad-spectrum triazole antifungal that is available in both **oral and intravenous** formulations [1]. - It is often used for invasive aspergillosis and other serious fungal infections [2]. *Amphotericin B* - **Amphotericin B** is a potent antifungal agent administered **intravenously** for severe systemic fungal infections [2]. - It has **poor oral bioavailability** and is not absorbed from the gastrointestinal tract, making it unsuitable for oral systemic therapy. - Oral formulations exist only for **local treatment** of GI candidiasis, not for systemic infections. *None of the options* - This option is incorrect because **griseofulvin** fits the description of being an antifungal that can be used orally but not intravenously.

Q: Colistin is obtained from ?

Bacteria. ***Bacteria*** - Colistin, also known as **polymyxin E**, is an antibiotic derived from the bacterium **Bacillus polymyxa subspecies colistinus** (now reclassified as *Paenibacillus polymyxa*). - It works by disrupting the **outer membrane** of Gram-negative bacteria, making it effective against multi-drug resistant strains. - While actinomycetes are also bacteria, in pharmacology, antibiotics from **Bacillus species** are categorized separately from actinomycete-derived drugs. *Fungi* - Many common antibiotics, such as **penicillin** and **cephalosporins**, are derived from fungi (e.g., *Penicillium*, *Cephalosporium*), but colistin is not one of them. - Fungal-derived antibiotics typically target bacterial **cell wall synthesis** or **protein synthesis**. *Actinomycetes* - **Actinomycetes**, particularly from the *Streptomyces* genus, are a rich source of antibiotics, including **streptomycin**, **tetracyclines**, and **erythromycin**. - While actinomycetes are technically bacteria, they are classified separately in pharmacology due to their unique characteristics and prolific antibiotic production. - Colistin is specifically produced by **Bacillus species**, not actinomycetes. *Herbs* - Herbs are used for traditional medicine and can have various therapeutic properties, but they do **not produce antibiotics** like colistin. - While some plant-derived compounds have antimicrobial activity, colistin is a product of **microbial fermentation**.

Q: Which of the following can prolong QT interval?

Gatifloxacin. ***Gatifloxacin*** - This **fluoroquinolone antibiotic** is known to cause **significant QT prolongation**, which can lead to serious cardiac arrhythmias like **Torsades de Pointes** [1]. - Among fluoroquinolones, gatifloxacin carries the **highest risk** of QT interval prolongation. - Its use has been **withdrawn or restricted** in many countries due to these **serious cardiac side effects** and dysglycemia, especially in patients with pre-existing cardiac conditions. - This is the **best answer** as it has the most clinically significant association with QT prolongation. *Nalidixic acid* - This is a **first-generation quinolone** primarily used for **urinary tract infections**. - While it can theoretically prolong QT interval, the **clinical significance is much lower** compared to fluoroquinolones. - It is **rarely implicated** in clinically significant QT prolongation in practice. *Ofloxacin* - Ofloxacin is a **second-generation fluoroquinolone** with a **moderate risk** of QT prolongation. - All fluoroquinolones carry a **class warning** for QT effects, but ofloxacin has **significantly lower risk** compared to gatifloxacin, moxifloxacin, and sparfloxacin. - It is considered **relatively safer** within the fluoroquinolone class for cardiac effects. *Pefloxacin* - Pefloxacin is another **second-generation fluoroquinolone** with **moderate QT prolongation potential**. - Like ofloxacin, it has a **comparatively lower risk** than gatifloxacin. - The **clinical incidence** of significant QT prolongation is **much less** than with newer fluoroquinolones.

Question 1

Which of the following causes retinal pigmentation?

Accepted Answer

Chloroquine

Answer

Quinine

Answer

Mefloquine

Answer

Atovaquone

Question 2

Which compound is primarily responsible for the hepatotoxicity associated with Isoniazid (INH)?

Accepted Answer

INH acetylhydrazine

Answer

INH sulfhydrazine

Answer

INH methylhydrazine

Answer

None of the options

Question 3

What is the approximate incidence of hepatotoxicity in patients receiving HAART?

Accepted Answer

10%

Answer

20%

Answer

30%

Answer

40%

Question 4

What are the active ingredients in Savlon antiseptic?

Accepted Answer

Cetrimide + Chlorhexidine

Answer

Cetrimide + Chlorhexidine + butyl alcohol

Answer

Cetrimide + butyl alcohol

Answer

Cetrimide + Cetavlon

Question 5

Which of the following is a topical antifungal agent?

Accepted Answer

Butenafine

Answer

Benzyl benzoate

Answer

Brimetenide

Answer

Posaconazole

Question 6

For systemic mycosis, fluconazole is preferred over ketoconazole because of:

Accepted Answer

All of the options

Answer

Lesser side effects

Answer

Greater efficacy

Answer

Longer t1/2

Question 7

Typhoid is treated by all except

Accepted Answer

Erythromycin

Answer

Amikacin

Answer

Ciprofloxacin

Answer

Ceftriaxone

Question 8

Which antifungal can be used orally but not intravenously?

Accepted Answer

Griseofulvin

Answer

Voriconazole

Answer

Amphotericin B

Answer

None of the options

Question 9

Colistin is obtained from ?

Accepted Answer

Bacteria

Answer

Fungi

Answer

Herbs

Answer

Actinomycetes

Question 10

Which of the following can prolong QT interval?

Accepted Answer

Gatifloxacin

Answer

Nalidixic acid

Answer

Pefloxacin

Answer

Ofloxacin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?